Curable polymer mixture

US9850373B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9850373-B2
Application numberUS-201113817003-A
CountryUS
Kind codeB2
Filing dateAug 3, 2011
Priority dateAug 18, 2010
Publication dateDec 26, 2017
Grant dateDec 26, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a composite formulation comprising a specific mediator additive component (A) of relatively high molecular weight, a filler component (B) and a binder component (C). The composite formulation can be cured to a composite which is especially suitable for the production of moldings.

First claim

Opening claim text (preview).

The invention claimed is: 1. Composite formulation containing i) 0.01 to 10.00 wt % of a mediator additive component (A), ii) 5 to 94 wt % of a filler component (B) and iii) 5 to 94 wt % of a binder component (C), wherein the mediator additive component (A) has a chemical structure containing the structural elements D, P and E shown in general formula (I) [D] a P[E] b   (I) with D the same or different and being selected from the group consisting of (D-I), (D-II), (D-III) and (D-IV) with R 1 the same or different and represented by hydrogen or CH 3 ; R 2 the same or different and represented by a branched or unbranched C 1 -C 24 -alkyl group, a the same or different and represented by an integer from 1 to 50, E the same or different and represented by hydrogen and/or being selected from the group consisting of (B-I), (B-II), (B-III) and (B-IV) with R 3 and R 4 in each case the same or different and represent hydrogen or a branched or unbranched C 1 -C 12 -alkyl group; R 5 and R 6 in each case are the same or different and represent hydrogen or a branched or unbranched C 1 -C 12 -alkyl group; R 7 , R 8 , R 9 and R 10 in each case are the same or different and represent hydrogen, COOH or a branched or unbranched C 1 -C 12 -alkyl group, b is the same or different and represents an integer from 1 to 50, P is the same or different and is represented by a branched or unbranched organic principal group, which contains at least two non-terminal ether oxygen atoms within the principal group, wherein the principal organic group represented by P has additional terminal oxygen atoms, the structural elements D and E are each bound directly to these terminal oxygen atoms, and a maximum of 70 mol % of the total structural elements E in the chemical structure according to the general formula (I) are H-atoms, and wherein the binder component (C) contains at least 60 wt % of preproducts (C′) selected from the group consisting of ethylenically unsaturated polymers, (meth)acrylate resins, and ethylenically unsaturated monomers; said preproducts (C′) curable by free radical polymerization with free radical initiators and/or free radical cross-linking with cross-linking agents. 2. Composite formulation according to claim 1 , containing i) 0.01 to 4.0 wt % of the mediator additive component (A), ii) 15 to 84 wt % of the filler component (B), and iii) 15 to 84 wt % of the binder component (C). 3. Composite formulation according to claim 1 , wherein in the general formula (I) describing the chemical structure of the mediator additive component (A), D is present as (D-II) and/or (D-IV), a is represented by an integer from 1 to 8, E comprises (B-I) and/or (B-II), and b is represented by an integer from 1 to 15, wherein a maximum of 50 mol % of the total structural elements E in the chemical structure according to general formula (I) are H-atoms and the organic principal radical represented by P has a molecular weight of at least 200, and at least two of the non-terminal ether oxygen atoms within the principal radical are connected to one another over a bridging linear C 2 -C 5 alkylene group segment of an unbranched or branched alkylene group. 4. Composite formulation according to claim 1 , wherein the total quantity or a partial quantity of the mediator additive component (A) is present in the form of compounds (A′) in which the organic principal group representing the structural element P has structural units that are obtainable by ring-opening polymerization of cyclic ethers containing 3 to 6 ring atoms, wherein the principal organic group optionally contains additional structural units that can be produced by ring-opening polymerization of lactones containing 5 to 7 ring atoms. 5. Composite formulation according to claim 4 , wherein the compounds (A′) have structural segments of general formula (II) wherein R 1 is the same or different and is H or CH 3 W is the same or different and is a repeat structural unit, x is the same or different and is an integer from 3 to 100, wherein the repeat structural unit W is obtained by ring-opening polymerization of a cyclic ether selected from the group comprising (W-I), (W-II), (W-III), (W-IV) and (W-V) wherein S 1 is the same or different and is H, a linear or branched C 1 to C 24 alkyl group, a C 6 to C 18 aryl group, or a C 6 to C 18 arylalkyl group, S 2 is the same or different and is H, a linear or branched C 1 to C 24 alkyl group, a C 6 to C 18 aryl group, or a C 6 to C 15 arylalkyl group, n is the same or different and is an integer from 0 to 10. 6. Composite formulation according to claim 1 , wherein the mediator additive component (A) is produced by a method that has steps i) and ii), in which in step i) hydroxy-functional preproducts are produced by ring-opening polymerization of oxetanes optionally substituted with hydroxyl groups, wherein the ring-opening polymerization takes place by reacting with said oxetanes an ethylenically unsaturated compound containing at least one hydroxyl group and in step ii) the hydroxy-functional preproducts are reacted with cyclic carboxylic acid anhydrides. 7. Composite formulation according to claim 6 , wherein the oxetanes used in step i) are each present in the form of oxetanes substituted with hydroxyl groups, wherein for the ethylenically unsaturated compound with at least one hydroxyl group used in step i), optionally hydroxyalkyl (meth)acrylate derivatives and/or allyl alcohol derivatives are selected, and the cyclic carboxylic acid anhydrides used in step ii) are optionally present as cyclic aliphatic carboxylic acid anhydrides containing at least 4 carbon atoms. 8. Composite formulation according to claim 7 , wherein the hydroxyalkyl (meth)acrylate derivatives are represented by hydroxyalkyl (meth)acrylate and/or ether species produced by alkoxylation of hydroxyalkyl (meth)acrylate and contain a maximum of 20 alkoxy structural units, and the allyl alcohol derivatives are present in the form of allyl alcohol and/or by alkoxylation of allyl alcohol, containing a maximum of 20 alkoxy structural units. 9. Composite formulation according to claim 1 , wherein at least 60 wt % of the filler component (B) is present in the form of filler component species (B′) which in each case according to DIN EN ISO 787-9 have a pH of at least 6.0. 10. Composite formulation according to claim 1 , wherein at least 60 wt % of the filler component (B) is present in the form of filler component species (B′) which in each case contain carbonates, hydrogen carbonates, sulfates and/or hydrogen sulfates of the elements calcium, magnesium and/or aluminum; and/or oxides, hydroxides and/or oxide-hydroxides of aluminum; and/or mica and/or aluminosilicates and/or talc and/or silicas. 11. Composite formulation according to claim 1 , wherein the binder component (C) contains at least 90 wt % of a polymer matrix preproduct consisting of the following components: (meth)acrylic resins and/or unsaturated polyester resins, ethylenically unsaturated monomers, optionally styrene, substituted styrenes, (meth)acrylates and/or (meth)acrylamides, species suitable as free radical initiators, optionally peroxide compounds and optionally, c

Assignees

Inventors

Classifications

  • Magnesium silicates, e.g. talc, sepiolite · CPC title

  • containing polyether side chains · CPC title

  • C08L33/12Primary

    Homopolymers or copolymers of methyl methacrylate · CPC title

  • on to polyethers, polyoxymethylenes or polyacetals {(C08F283/004 takes precedence)} · CPC title

  • Acrylates · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9850373B2 cover?
The invention relates to a composite formulation comprising a specific mediator additive component (A) of relatively high molecular weight, a filler component (B) and a binder component (C). The composite formulation can be cured to a composite which is especially suitable for the production of moldings.
Who is the assignee on this patent?
Nagelsdiek Rene, Göbelt Bernd, Gertzen Bärbel, and 5 more
What technology area does this patent fall under?
Primary CPC classification C08L33/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).